Unilife Corp  

(Public, OTCMKTS:UNISQ)   Watch this stock  
Find more results for NASDAQ:UNIS
0.111
-0.009 (-7.29%)
Apr 28 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.11 - 0.12
52 week 0.09 - 5.79
Open 0.11
Vol / Avg. 108,258.00/889,664.00
Mkt cap 1.52M
P/E     -
Div/yield     -
EPS -5.15
Shares 18.15M
Beta -1.02
Inst. own 16%
Feb 10, 2017
Q2 2017 Unilife Corp Earnings Release
  

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin -654.23% -679.09%
Operating margin -446.41% -678.77%
EBITD margin - -482.08%
Return on average assets -78.00% -109.51%
Return on average equity - -
Employees 160 -
CDP Score - -

Address

250 Cross Farm Ln
YORK, PA 17406-6200
United States - Map
+1-717-3843400 (Phone)
+1-302-6555049 (Fax)

Website links

Description

Unilife Corp is engaged in the designing, development and manufacturing of injectable drug delivery systems. The Company has a portfolio of product platforms, including pre-filled syringes, disposable and reusable auto-injectors, drug reconstitution delivery systems, ocular delivery systems, and other systems for the targeted delivery of injectable therapies. The majority of its products are designed for sale directly to pharmaceutical and biotechnology companies supplying them as drug-device combination products, pre-filled and ready for administration by end-users, such as health-care providers or patients. Its other products, such as reusable auto-injectors and certain systems for targeted drug delivery are designed either to be sold to pharmaceutical or biotechnology companies for use as combination products or to be sold directly to a health care provider or end user without having the device pre-filled by a pharmaceutical company.

Officers and directors

John C. Ryan J.D. President, Chief Executive Officer, Director
Age: 47
David Hastings Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Age: 55
Ian Hanson Chief Operating Officer, Senior Vice President
Age: 43
Stephanie Walters Senior Vice President, General Counsel, Secretary
Age: 39
Molly Weaver Ph.D. Chief Compliance Officer, Vice President - Quality and Regulatory Affairs
Age: 36
Mary Katherine Wold Non-Executive Chairman of the Board, Lead Independent Director
Age: 63
Rosemary A. Crane Director
Age: 57
Duane M. DeSisto Director
Age: 62
Jeff Carter Non-Executive Director
Age: 58
Harry A. Hamill CPA Independent Director
Age: 62